A world leader
  in patient-centered care


Training the next generation
  of cancer researchers


The most advanced
  treatment options available

The New York Times Magazine logo

The New York Times Magazine, May 15: ‘Learning from the Lazarus Effect’

Some clinical trials can be unsuccessful for all but a small number of participants; these are patients who experience an "exceptional response" to treatment — putting the brakes on their cancer. The May 15 edition of The New York Times Magazine features stories about Dana-Farber patients, clinicians, and researchers, and what we can learn from "exceptional responders" to benefit others.

Investigational drug abemaciclib shows promising activity against several cancer types

May 23, 2016

Dana-Farber physician-researchers report in a new study that the CDK inhibitor abemaciclib yielded encouraging and durable results against several different types of cancers, including breast cancer, lung cancer, glioblastoma, and melanoma.

Discover Care Believe - boy on pier

"Discover. Care. Believe." highlights Dana-Farber breakthroughs

Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.

What do you #DiscoverCareBelieve?

Charles Fuchs, MD, MPH

New Online Resource for Precision Cancer Medicine

Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.

Evidence suggesting link between cancer and light therapy for newborn jaundice is inconclusive but warrants consideration
May 23, 2016

Two new studies raise enough questions about a possible link between childhood cancer and light therapy for newborn jaundice that clinicians should exercise caution in prescribing the treatment for infants whose jaundice is likely to resolve on its own, according to an editorial published in the journal Pediatrics. The suggestion of a link, however, should not deter use of the treatment, also known as phototherapy, in babies who otherwise would be at risk of brain damage or hearing loss.

Dana-Farber research presented at 2016 ASCO conference
May 20, 2016

Dana-Farber investigators will present over 70 research presentations at the American Association of Clinical Oncology (ASCO) annual meeting in Chicago next month.

Dana-Farber’s MatchMiner wins Harvard Business School’s Precision Trials Challenge
May 20, 2016

MatchMiner, an open computational platform developed at Dana-Farber Cancer Institute for matching patient-specific genomic profiles to precision cancer medicine clinical trials, has been named the winner of the Precision Trials Challenge.

Ixazomib improves effectiveness of combination therapy in relapsed/resistant multiple myeloma, phase 3 trial shows
April 26, 2016

Study shows patients with relapsed, treatment-resistant multiple myeloma responded better to a combination of ixazomib, lenalidomide, and dexamethasone than to lenalidomide and dexamethasone alone.

Targeted therapy gives lung cancer patients hope (WGME-TV Maine)

May 23, 2016

Dr. Geoffrey Oxnard is profiled along with one of his patients concerning targeted therapies to treat lung cancer.

Cancer Drug Keytruda Keeps Some Patients Alive For 3 Years (NBC Nightly News)
May 19, 2016

Dr. F. Stephen Hodi helped lead research showing the cancer drug Keytruda has helped about 40 percent of melanoma patients survive longer.

Location Of Cancer On Colon May Predict Patient’s Survival Chances (WBZ-TV Boston)
May 19, 2016

Dr. Jeffrey Meyerhardt helped lead research showing the location of a patient’s colon cancer may predict survival outcomes.


A Behind the Scenes Look at the People Helping to Usher in New Cancer Therapies: A Nurse’s Story (Huffington Post)
May 17, 2016

Nurse Joan Lucca comments on working with the Stand Up To Cancer Research Institute Immunology Dream Team.

Could extreme breath-holding help in breast cancer treatment (Boston Globe)
May 12, 2016

Dr. Jay Harris commented on a study showing extreme breath-holding like that practiced by free divers may have usefulness in treating patients.

Additional Treatments Offer Little Benefit for Pancreatic Cancer: Study (US News & World Report)
May 06, 2016

Dr. Deborah Schrag wrote an editorial for JAMA talking about the need for more treatments for Pancreatic Cancer.

New Test Diagnoses Cancer Faster, Offers Patients Better Treatment (WBZ-TV Boston)
April 28, 2016

Researchers at Dana Farber helped develop a new test called a Rapid Heme Panel to diagnose patients faster.

Fitbits Could Help Find New Breast Cancer Treatments (Boston Magazine)
April 28, 2016

Dr. Jennifer Ligibel is leading research to see if weight loss can prevent breast cancer recurrence.

Women's Exercise Class (Tuesdays)(4)

May 24, 2016

10:00 AM - 11:00 AM

BodyScapes, 77 Avenue Louis Pasteur

Women's exercise classes are for female patients only and require consultation prior to participation. Please call 617-632-4523 to book a consultation and to receive more information about class participation. more

Mindfulness Meditation (Tuesdays)

May 24, 2016

11:00 AM - 11:45 AM

Stoneham Patient Services Suite, Smith Bldg., Room 330

Mindfulness meditation can help you relax, reduce anxiety, stress and negative emotions as well as increase your sense of well-being. In this one hour class, you will learn techniques to help focus your mind on the present moment to raise awareness of your thoughts with acceptance, patience, and compassion.


This class is open to patients who have been newly diagnosed with cancer, are receiving treatment, or are in remission. Family, friends, and staff are also welcome.

Sessions are led by Patty Arcari, RN, PhD, Program Manager for Meditation and Mindfulness Programming, Zakim Center. Please contact the Zakim Center for more information at 617-632-3322 or email zakim_center@dfci.harvard.edu


Beginners Crochet

May 24, 2016

12:00 PM - 2:00 PM

Blum Resource Center, 1st Floor, Yawkey Center

Patients, family, caregivers, and staff are invited to stop by the Creative Arts Studio to create with artists and art therapists, and explore how expressive arts can support stress and pain management. All levels are welcome, no experience is required, and an array of materials is provided free of charge. For more information and to register, please contact the Zakim Center at 617-632-3322 or email Zakim_Center@dfci.harvard.edu. more

  • Patient referral information, clinical resources and more.

  • Make an Appointment

    For adults:

    Quick access: Appointments as soon as the next day for new adult patients

    For children:

    Request Appointment Online

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2015-2016 logo    U.S. News Best Children's Hospitals Cancer 2015-2016 logo 

    Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)

  • Dana-Farber Blog

    Insight Blog screenshot

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now

5/24/2016 11:39:59 AM